Altshuler Shaham’s CATALENT, INC. CTLT Stock Holding History

Altshuler Shaham’s Portfolio CTLT Stock Details CTLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-468	Closed	-$49K	–	548
2020 Q4	$49K	Buy	468 +162	+53%	+$15.7K	﹤0.01%	268
2020 Q3	$26K	Buy	306 +58	+23%	+$4.9K	﹤0.01%	304
2020 Q2	$18K	Buy	+248	New	+$16.8K	﹤0.01%	271
2019 Q4	–	Sell	-180	Closed	-$9K	–	645
2019 Q3	$9K	Buy	+180	New	+$9.67K	﹤0.01%	311

Other funds holding CTLT

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Altshuler Shaham's CTLT Position: Q1 2021 in Review

Altshuler Shaham sold out of CATALENT, INC. (CTLT) in Q1 2021, closing a stake of 468 shares — an estimated $49K sold.

Altshuler Shaham first reported a position in CTLT in Q3 2019 and held it in 4 quarters. The position peaked at $49K in Q4 2020. 500 funds tracked by Wall St. Rank hold CTLT as of Q1 2021.

Altshuler Shaham reported no remaining CATALENT, INC. position as of Q1 2021 after selling out during the quarter.
Altshuler Shaham sold 468 CATALENT, INC. shares in Q1 2021, an estimated $49K.
Altshuler Shaham first reported a position in CATALENT, INC. in Q3 2019 and held it in 4 quarters.
Altshuler Shaham's CATALENT, INC. position peaked at $49K in Q4 2020.
500 funds tracked by Wall St. Rank held CATALENT, INC. as of Q1 2021.

Based on Altshuler Shaham's 13F filing for Q1 2021, filed 13 May 2021.